ARCHIVES

Investigators Plan To Interview DeVita, Mendelsohn on C225 Development

This article is from The Cancer Letter archive.

Vol. 28 No. 27 | July 5, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Balks At Forming New Review Groups For NCI’s Program Grants; Guidelines Draft Ready For NCAB

August 2, 1974

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

NCI Barred PI Wolmark And Its Own Prevention Staff From Ad Hod Meeting.

April 20, 2007

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Stronger Measures Needed To Reduce U.S. Smoking, IOM Says.

June 1, 2007